Narrative Review: Addressing Covid-19 Vaccine Concerns in Special and Vulnerable Populations.

education infectious diseases pediatrics pharmacists pregnancy/lactation vaccines

Journal

Hospital pharmacy
ISSN: 0018-5787
Titre abrégé: Hosp Pharm
Pays: United States
ID NLM: 0043175

Informations de publication

Date de publication:
Aug 2022
Historique:
entrez: 28 7 2022
pubmed: 29 7 2022
medline: 29 7 2022
Statut: ppublish

Résumé

Public health advocates and healthcare professionals (HCPs) have been challenged with vaccine hesitancy and addressing misinformation. In order for HCPs and pharmacists, in particular, to serve as effective stewards of COVID-19 vaccine science in the interest of the public good, it is imperative for HCPs to appreciate the various factors contributing to vaccine hesitancy and vaccine distrust. A PubMed search was performed and relevant articles on COVID-19 vaccine in populations of interest were included. Information from health agencies, such as the Centers for Disease Control and Prevention (CDC) as well as established professional health societies was incorporated for guidance. This review focuses on COVID-19 vaccine concerns in the populations of children, pregnancy and lactation, immunocompromised, and religious and ethnic disparities. We also discuss post emergency use authorization experience with respect to vaccine safety including annotations on Guillain-Barré Syndrome, myocarditis and pericarditis, and thrombosis with thrombocytopenia syndrome.

Identifiants

pubmed: 35898240
doi: 10.1177/00185787211066463
pii: 10.1177_00185787211066463
pmc: PMC9310301
doi:

Types de publication

Journal Article

Langues

eng

Pagination

575-587

Informations de copyright

© The Author(s) 2022.

Déclaration de conflit d'intérêts

Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Références

Curr Infect Dis Rep. 2020;22(11):29
pubmed: 32982599
J Transl Autoimmun. 2020 Apr 09;3:100051
pubmed: 32292901
N Engl J Med. 2020 Nov 12;383(20):1920-1931
pubmed: 32663912
Am J Obstet Gynecol. 2021 Sep;225(3):303.e1-303.e17
pubmed: 33775692
Clin Exp Immunol. 2020 Nov;202(2):149-161
pubmed: 32671831
N Engl J Med. 2021 Jul 8;385(2):97-100
pubmed: 33789007
MMWR Morb Mortal Wkly Rep. 2021 Nov 05;70(44):1545-1552
pubmed: 34735422
JAMA Pediatr. 2021 Feb 1;175(2):143-156
pubmed: 32975552
J Glob Health. 2021 Jun 26;11:05015
pubmed: 34221360
J Pediatr. 2020 Dec;227:45-52.e5
pubmed: 32827525
Pediatr Res. 2021 Nov;90(5):966-970
pubmed: 33627824
Ann Intern Med. 2021 Mar;174(3):362-373
pubmed: 33253040
Clin Infect Dis. 2018 Jul 18;67(3):464-471
pubmed: 29471452
Proc Natl Acad Sci U S A. 2014 Aug 26;111(34):12283-7
pubmed: 25136134
Lancet Infect Dis. 2019 Sep;19(9):988-1000
pubmed: 31399377
MMWR Morb Mortal Wkly Rep. 2021 Jul 09;70(27):977-982
pubmed: 34237049
Cleve Clin J Med. 2020 Nov 2;87(11):695-703
pubmed: 33139263
J Cult Divers. 2007 Summer;14(2):56-60
pubmed: 19175244
Open Forum Infect Dis. 2021 Jun 30;8(7):ofab353
pubmed: 34337100
Science. 2020 Jun 12;368(6496):1170-1171
pubmed: 32527809
N Engl J Med. 2001 Feb 1;344(5):375-9
pubmed: 11172172
Nature. 2020 Oct;586(7830):589-593
pubmed: 32785213
J Immunother Cancer. 2020 Jul;8(2):
pubmed: 32611687
JAMA Intern Med. 2021 Jul 1;181(7):1008-1011
pubmed: 33783471
BMJ. 2002 Aug 24;325(7361):430-2
pubmed: 12193361
JAMA. 2021 Aug 24;326(8):728-735
pubmed: 34251417
N Engl J Med. 2021 Oct 14;385(16):1536
pubmed: 34496198
Pediatrics. 2021 Sep;148(3):
pubmed: 34088762
JAMA Cardiol. 2021 Oct 1;6(10):1115-1117
pubmed: 34185047
N Engl J Med. 2021 Feb 4;384(5):e12
pubmed: 33471971
Clin Infect Dis. 2014 Feb;58(3):e44-100
pubmed: 24311479
JAMA. 2021 Feb 23;325(8):719-720
pubmed: 33480972
N Engl J Med. 2021 Oct 7;385(15):1393-1400
pubmed: 34525275
N Engl J Med. 2022 Jan 6;386(1):35-46
pubmed: 34752019
Clin Infect Dis. 2021 Jul 15;73(Suppl 1):S24-S31
pubmed: 33977298
Hum Vaccin Immunother. 2016 Sep;12(9):2351-6
pubmed: 27269431
MMWR Morb Mortal Wkly Rep. 2021 Apr 30;70(17):651-656
pubmed: 33914723
Turk Pediatri Ars. 2014 Sep 01;49(3):181-5
pubmed: 26078660
JAMA. 2021 Mar 16;325(11):1074-1087
pubmed: 33625505
JAMA. 2021 May 4;325(17):1784-1786
pubmed: 33720292
Lancet Glob Health. 2021 Jun;9(6):e749-e750
pubmed: 33713634

Auteurs

Kent A Owusu (KA)

Yale New Haven Health, New Haven, CT, USA.
Yale New Haven Hospital, New Haven, CT, USA.

Muhammad K Effendi (MK)

Ernest Mario School of Pharmacy, Piscataway, NJ, USA.

Melissa L Thompson Bastin (ML)

University of Kentucky HealthCare, Lexington, KY, USA.

Samad Tirmizi (S)

Yale New Haven Hospital, New Haven, CT, USA.

Ishaq Lat (I)

Shirley Ryan AbilityLab, Chicago, IL, USA.

Mahmoud A Ammar (MA)

Yale New Haven Hospital, New Haven, CT, USA.

Classifications MeSH